Syringes Market Size
| Study Period | 2021 - 2029 |
| Market Size (2024) | USD 18.37 Billion |
| Market Size (2029) | USD 27.85 Billion |
| CAGR (2024 - 2029) | 8.68 % |
| Fastest Growing Market | North America |
| Largest Market | Asia-Pacific |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Syringes Market Analysis
The Syringe Market size is estimated at USD 18.37 billion in 2024, and is expected to reach USD 27.85 billion by 2029, growing at a CAGR of 8.68% during the forecast period (2024-2029).
COVID-19 had a significant impact on the syringe market owing to the rise in the development of vaccines, which led to an increased demand for syringes. Since the outbreak of the pandemic had disrupted the whole healthcare system, the industry faced a shortage of syringes that meet the requirements for the large patient pool. For instance, as per the UN report published in November 2021, based on a scenario in which approximately seven billion people require two doses of coronavirus vaccine over the vaccination period, the UN health agency predicted that a shortage of at least one billion syringes could occur if manufacturing does not improve. However, now that the pandemic's restrictions have been lifted and the spread has been reduced, the market is moving at a slow pace as many companies reduced production of syringes as the vaccination drives reduced. For instance, in October 2022, Hindustan Syringes & Medical Devices (HMD), a manufacturer of disposable syringes and auto-disposable syringes, reduced production of syringes from over 40 lakh per day of AD syringes to 5-6 lakh daily as the government either suspended or rescheduled its orders due to decreased demand for vaccination.
Furthermore, the major factors driving the growth of the syringe market include the growing prevalence of chronic and infectious diseases. As per the International Diabetes Federation 2021 report, the number of people living with diabetes was around 537 million (20-79 years) in the year 2021. Additionally, the number of people living with diabetes is expected to increase from 643 million in 2030 to nearly 783 million by 2045 globally. Most of the diagnostic and therapeutic techniques for chronic diseases require syringes, as these play a vital role during tests and drug administration, and thus the growing burden of diseases is expected to drive the growth of the market.
Moreover, the increased adoption of injectable drugs, technological advancements in syringes, and the growing number of vaccination and immunization programs are expected to drive the volume growth over the next few years. For instance, in January 2022, Nephron Pharmaceuticals Corporation launched the cyclic olefin copolymer syringe (COC). It has a glass-like appearance but is break-resistant and lightweight. COC syringes are suitable for a variety of medications, including highly viscous drugs, and provide an extended product shelf-life. The disconnected plunger allows for easier storage. Also, the expansion of facilities for the production of syringes is anticipated to contribute to the growth of the market. For instance, in June 2022, WuXi Biologics launched the GMP operation of its new drug product facility, DP5, which is located in Wuxi, China. It is a manufacturing facility for the production of vials and pre-filled syringes.
Hence, owing to the rise in chronic diseases, the increase in the adoption of injectable drugs, and technological advances in syringes, the syringe market is expected to witness rapid growth over the forecast period. However, the rise in the incidence of needle-stick injuries, the high cost associated with safe syringes, and the availability of alternate drug delivery methods are likely to hinder the growth of the syringe market globally.
Syringes Market Trends
This section covers the major market trends shaping the Syringe Market according to our research experts:
Pre-Fillable Syringes Segment is Expected to Witness a Significant Growth in the Syringe Market Over the Forecast Period
A pre-fillable syringe is a disposable syringe that is used to remove a drug product from a vial for administering through various routes. They are generally preferred for the parenteral administration of various drugs, and they are used mainly for the treatment of chronic diseases such as cancer, diabetes, and several other diseases. By eliminating the withdrawal phase and delivering the medication product straight to the patient, a pre-fillable syringe device can administer a more precise dose of the drug while minimizing needle exposure.
The pre-fillable syringes segment is likely to witness growth over the forecast period owing to the factors such as a rise in chronic, infectious diseases, an increase in the adoption of injectable drugs, and technological advancements in the field of syringes. For instance, as per the IDF Diabetes Atlas 10th edition, the number of adults with diabetes in Europe is expected to reach 67 million by 2030 and 69 million by 2045.
Additionally, the approval by the regulatory authorities, product launches, and collaborations is also boosting the growth of the segment over the forecast period. For instance, in June 2022, West Pharmaceutical Services, Inc., a company that produces innovative solutions for injectable drug administration, unveiled its new pre-fillable Daikyo Crystal Zenith 2.25mL Insert Needle Syringe System at BIO International Convention. Furthermore, in June 2022, BD (Becton, Dickinson, and Co.) and Mitsubishi Gas Chemical Co. Inc. (MCG) signed a letter of intent to discuss a partnership to explore new ways to advance pre-fillable syringe technology for biologic drug delivery. Specifically, the agreement states that they are anticipated to investigate further development of Oxycapt, an innovation from MGC that integrates what it calls the best of plastic and glass for the plastic syringe.
Hence, owing to the rise in chronic diseases, increase in product launches, and collaboration in the field of pre-fillable syringes, the pre-fillable syringe segment of the market studied is expected to witness rapid growth over the forecast period.
Asia-Pacific is Expected to Witness a Growth in the Syringe Market Over the Forecast Period
The Asia-Pacific market for syringes is expected to witness healthy growth during the forecast period. Factors such as improving economic conditions, the rise in purchasing power of the people, the growth in awareness regarding the advantages of pre-fillable syringes, and the presence of a large patient pool suffering from various chronic diseases are expected to drive the market in the Asia-Pacific region. For instance, as per the IDF 2021 report, in Asia, the number of adults with diabetes is expected to reach 113 million by 2030 and 151 million by 2045. Hence, as the number of diabetic populations rises, the demand for syringe utilization rises, thereby boosting market growth over the forecast period.
The increased focus of market players on product launches and production expansion also drives the market growth in the region. For instance, in August 2021, the medical syringe manufacturer Hindustan Syringes & Medical Devices Ltd (HMD) achieved a milestone of producing over 1 crore assorted-size syringes daily. Also, the strategic initiatives taken by the market players are expected to propel the growth of the market. For instance, in April 2021, West Pharmaceutical Services, Inc. extended its partnership with domestic Indian pharma company Venus Remedies Ltd. to deliver the NovaGuard SA Pro safety system. It helps biopharmaceutical manufacturers package drugs in a prefillable syringe with a needlestick prevention feature.
The surge in recent product approval in the market led to the availability of novel and advanced products, thereby impacting the adoption and leading to the growth of the syringe market.
Syringes Industry Overview
The syringe market is highly fragmented, with the presence of a large number of local and international players. Key players adopt different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key market players are Gerresheimer AG, B Braun, Hindustan Syringes & Medical Devices Limited, and Terumo Corporation, among others.
Syringes Market Leaders
-
Becton Dickinson and Company
-
B. Braun Melsungen AG
-
Hindustan Syringes & Medical Devices Limited
-
Gerresheimer AG
-
Terumo Corporation
*Disclaimer: Major Players sorted in no particular order
Syringes Market News
- October 2022: Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation and manufacturer of primary container, injection, and infusion therapy devices, launched a ready-to-fill polymer syringe for challenging biotech drugs with a larger volume. The PLAJEX 2.25 mL with Tapered Needle is specifically designed to meet the Biotech market, making it suitable for complex drug applications, such as high-viscosity biotech medications.
- September 2022: BD (Becton, Dickinson, and Company) introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination, and integrity. The new BD Effivax Glass Prefillable Syringe was designed in collaboration with pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing.
Syringes Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Burden of Chronic Diseases and Infectious Diseases
- 4.2.2 Increase In the Number of Mass Vaccination Programs
- 4.2.3 Rise In the Trend of Self-Administration of Injections Along with Greater Dose Precision Associated with Injections
-
4.3 Market Restraints
- 4.3.1 Growing Cases of Needle-stick Injuries, Coupled with High Cost of Safety Syringes
- 4.3.2 Availability of Alternate Drug Delivery Methods
-
4.4 Porter Five Forces
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
5.1 By Usage
- 5.1.1 Sterilizable/Reusable Syringes
- 5.1.2 Disposable Syringes
- 5.1.2.1 Conventional Syringes
- 5.1.2.2 Safety Syringes
- 5.1.2.3 Prefillable Syringes
-
5.2 By Application
- 5.2.1 Diabetes
- 5.2.2 Botox
- 5.2.3 Osteoarthritis
- 5.2.4 Human Growth Hormone
- 5.2.5 Other Applications
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Becton Dickinson and Company
- 6.1.2 B. Braun Melsungen AG
- 6.1.3 Gerresheimer AG
- 6.1.4 Hindustan Syringes & Medical Devices Limited
- 6.1.5 Terumo Corporation
- 6.1.6 Nipro Corporation
- 6.1.7 Schott AG
- 6.1.8 Cardinal Health Inc.
- 6.1.9 M.C. Johnson Company
- 6.1.10 Changzhou Mingle Medical Equipment Co., Ltd.
- 6.1.11 Hi-Tech Syringes
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablitySyringes Industry Segmentation
As per the scope of the report, the syringe is a device used by medical professionals to transfer liquids into or out of the body. It is made up of a hollow needle, which is attached to a tube and a plunger. The Syringe Market is segmented by Usage (Sterilizable/Reusable Syringes, and Disposable Syringes (Conventional Syringes, Safety Syringes, Pre-fillable Syringes), Application (Diabetes, Botox, Osteoarthritis, Human Growth Hormone, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above-mentioned segments.
| By Usage | Sterilizable/Reusable Syringes | |
| Disposable Syringes | Conventional Syringes | |
| Safety Syringes | ||
| Prefillable Syringes | ||
| By Application | Diabetes | |
| Botox | ||
| Osteoarthritis | ||
| Human Growth Hormone | ||
| Other Applications | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Syringes Market Research FAQs
How big is the Syringe Market?
The Syringe Market size is expected to reach USD 18.37 billion in 2024 and grow at a CAGR of 8.68% to reach USD 27.85 billion by 2029.
What is the current Syringe Market size?
In 2024, the Syringe Market size is expected to reach USD 18.37 billion.
Who are the key players in Syringe Market?
Becton Dickinson and Company, B. Braun Melsungen AG, Hindustan Syringes & Medical Devices Limited, Gerresheimer AG and Terumo Corporation are the major companies operating in the Syringe Market.
Which is the fastest growing region in Syringe Market?
North America is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Syringe Market?
In 2024, the Asia-Pacific accounts for the largest market share in Syringe Market.
What years does this Syringe Market cover, and what was the market size in 2023?
In 2023, the Syringe Market size was estimated at USD 16.90 billion. The report covers the Syringe Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Syringe Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Syringes Industry Report
The Global Syringes Market is segmented by usage into sterilizable/reusable syringes and disposable syringes, and by application into diabetes, botox, osteoarthritis, human growth hormone, and other applications. The market analysis includes a market forecast outlook, providing insights into market trends and industry outlook. The report offers a comprehensive market review, covering market value and market segmentation across different geographies such as North America, Europe, Asia-Pacific, Middle East and Africa, and South America.
The industry analysis highlights the market growth and market overview, focusing on the market leaders and industry size. The market data provided in the report offers a detailed market prediction and industry research, supported by industry statistics and market forecast. The report also includes an industry report example and report PDF for further reference.
The market outlook and industry information are essential for understanding the market trends and industry sales. The market segmentation in the report helps in identifying the market value and market growth rate. The industry reports and research companies provide valuable insights into the market leaders and market predictions. The report pdf download offers a detailed market review and market overview, making it a valuable resource for industry analysis and industry research.
